Outcome of different activity of 131I for first remnant ablation in the patients with differentiated thyroid cancer

被引：0
|
作者：
Chen, Yonghui [1 ]
机构：
[1] Beijing Union Med Coll Hosp, Nucl Med, Beijing, Peoples R China
来源：
JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
2048
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer
    Doi, SAR
    Woodhouse, NJY
    CLINICAL ENDOCRINOLOGY, 2000, 52 (06) : 765 - 773
  • [2] Review:: 131I activity for remnant ablation in patients with differentiated thyroid cancer:: A systematic review
    Hackshaw, Allan
    Harmer, Clive
    Mallick, Ujjal
    Haq, Masud
    Franklyn, Jayne A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (01): : 28 - 38
  • [3] Lowest effective 131I activity for thyroid remnant ablation of differentiated thyroid cancer patients Dosimetry-based model for estimation
    Jentzen, W.
    Moldovan, A. -S.
    Ruhlmann, M.
    Goerges, R.
    Bockisch, A.
    Rosenbaum-Krumme, S.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2015, 54 (03): : 137 - 143
  • [4] Radiometabolic Therapy with 131I for the Ablation of the Thyroid Remnant in Patients Affected by Differentiated Thyroid Cancer: Comparison Between Four Different Activities.
    Campenni, A.
    Ruggeri, R. M.
    Castorina, S.
    Cardile, D.
    Vigneri, C.
    Cucinotta, M.
    Amato, E.
    Sindoni, A.
    Baldari, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S424 - S424
  • [5] Dosimetry of 131I in remnant ablation and metastasis of differentiated thyroid cancer treated with high radioactivities and rhTSH
    Ramirez-Franco, Jorge
    Torres-Garcia, Eugenio
    Flores-Reyes, Mario
    Torres-Garcia, Gustavo
    Perez-Soto, Elvia
    RADIATION EFFECTS AND DEFECTS IN SOLIDS, 2024, 179 (9-10): : 1284 - 1294
  • [6] TSH ≥30 mU/L may not be necessary for successful 131I remnant ablation in patients with differentiated thyroid cancer
    Ju, Nianting
    Hou, Liying
    Song, Hongjun
    Qiu, Zhongling
    Wang, Yang
    Sun, Zhenkui
    Luo, Quanyong
    Shen, Chentian
    EUROPEAN THYROID JOURNAL, 2023, 12 (04)
  • [7] Fixed dosage of 131I for remnant ablation in patients with differentiated thyroid carcinoma without pre-ablative diagnostic 131I scintigraphy
    de Klerk, JMH
    de Keizer, B
    Zelissen, PMJ
    Lips, CMJ
    Koppeschaar, HPF
    NUCLEAR MEDICINE COMMUNICATIONS, 2000, 21 (06) : 529 - 532
  • [8] Rare adverse effect of discontinuation of levothyroxine treatment for 131I ablation of thyroid remnant in a patient with differentiated thyroid cancer
    Luque-Ramirez, Manuel
    Gomez Ramirez, Joaquin
    Azcarate Villalon, Andrea
    Martin Perez, Elena
    Larranaga Barrera, Eduardo
    ENDOCRINOLOGIA Y NUTRICION, 2013, 60 (07): : 412 - 414
  • [9] Guidelines for the prescribed activity for 131I remnant ablation on differentiated thyroid cancer: A distillation and comparison of guidelines from seven organizations
    Guan, Haixia
    Van Nostrand, Douglas
    Li, Yaming
    Orquiza, Michael
    Teng, Weiping
    Khorjekar, Gauri
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54
  • [10] Dosimetric approach to 131I ablation therapy for the differentiated thyroid cancer
    Gortan, Fatma Arzu
    Yuksel, Alptug Ozer
    Gulaldi, Nedim Cuneyt Murat
    Coskun, Nazim
    Akca, Ceren Deniz Kapulu
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2022, 25 (03) : 260 - 268
12345